About
Michael Shuster is a partner in Goodwin's Life Sciences group, providing strategic intellectual property advice to biotechnology, pharmaceutical, and other life sciences companies. He handles IP matters including patent prosecution, portfolio analysis, due diligence, litigation, and opinion work, and also provides IP evaluation and counseling for companies raising capital, executing strategic partnerships, and going public.
Practice areas
Intellectual PropertyPatent ProsecutionPatent LitigationIP Strategy
Office
Expertise
Life SciencesBiotechnologyPharmaceuticalChemicalImmunotherapyAntibody TechnologiesMicrobiome TechnologiesBiologicsGene TherapySynthetic BiologySmall Molecule TherapeuticsDrug Formulations
Education
- JD, University of San Francisco School of Law (cum laude)
- PhD, Columbia University, The Department of Physiology and Molecular Biophysics
- BA, Biophysics, Brandeis University (magna cum laude)
